• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

Clinical Trials

Posted inClinical Trials, In the Pipeline, Neuroscience

Treating Parkinson’s Disease: Betting on Alpha-Synuclein

by Mark Gubar and Julia Mardi January 14, 2022April 11, 2024

The pharmaceutical industry continues to fight hard against the devastating neurodegenerative disease.

T cell.
Posted inAutoimmune Diseases, Clinical Trials, Neuroscience

Even Severe Multiple Sclerosis Can Be Cured

by Nik Resovski and Julia Mardi January 11, 2022September 8, 2022

Atara Biotherapeutics and its awesome T-cell therapy against Epstein–Barr virus can really cure progressive forms of multiple sclerosis.

brain
Posted inClinical Trials, Neuroscience

Buntanetap: Breakthrough in Treatment of Alzheimer’s and Parkinson’s

by Mark Gubar January 11, 2022September 8, 2022

Buntanetap acts simultaneously on three neurotoxic proteins responsible for neurodegenerative disorders: amyloid beta, alpha-synuclein, and tau protein.

Posted inClinical Trials, COVID-19, Infections

Ensovibep: Drug for All Variants of Coronavirus Including Omicron

by Mark Gubar January 10, 2022September 8, 2022

Molecular Partners and Novartis believe in the success of DARPins.

Posted inClinical Trials, COVID-19, Infections

Black Seed for Coronavirus Treatment

by Mark Gubar January 6, 2022September 8, 2022

Nigella sativa, or Prophetic medicine, as a possible cure for COVID-19.

Posted inClinical Trials, COVID-19, Infections

Molnupiravir: New Effective Pill for Coronavirus. All That We Know

by Tanya von Reuss and Nik Resovski December 14, 2021September 8, 2022

Molnupiravir pills by Merck & Co. can help COVID-19 patients avoid going to the hospital or dying.

coronavirus
Posted inClinical Trials, COVID-19, Infections

Sotrovimab Is Effective Against Omicron Variant of Coronavirus

by Julia Mardi December 9, 2021September 8, 2022

A monoclonal antibody developed by GlaxoSmithKline and Vir Biotechnology successfully counteracts a new strain of SARS-CoV-2.

Posts pagination

Newer posts 1 … 3 4 5 6 7 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×